Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low-Dose Adjunctive Brexpiprazole in the Treatment of Bipolar I Depression: An Open-Label Study

NCT04569448 is registered in ClinicalTrials.gov with Douglas Mental Health University Institute as lead sponsor.

NCT NCT04569448
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04569448 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low-Dose Adjunctive Brexpiprazole in the Treatment of Bipolar I Depression: An Open-Label Study
Lead sponsor
Douglas Mental Health University Institute
Phase
Phase 3
Overall status
Recruiting
Start date
May 10, 2021
Completion date
December 31, 2030
Enrollment
58 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar depression